GAMMA Investing’s Olema Pharmaceuticals OLMA Stock Holding History

GAMMA Investing’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.79K	Sell	555 -41	-7%	-$447	﹤0.01%	3666
2026 Q2	$7.46K	Buy	596 +8	+1%	+$107	﹤0.01%	3327
2026 Q1	$8.77K	Sell	588 -135	-19%	-$3K	﹤0.01%	3136
2025 Q4	$18.1K	Buy	723 +492	+213%	+$8.76K	﹤0.01%	2670
2025 Q3	$2.26K	Buy	+231	New	+$1.39K	﹤0.01%	3421
2025 Q1	–	Sell	-321	Closed	-$1.87K	–	3860
2024 Q4	$1.87K	Buy	321 +58	+22%	+$579	﹤0.01%	3239
2024 Q3	$3.14K	Buy	263 +207	+370%	+$2.65K	﹤0.01%	2920
2024 Q2	$606	Buy	56 +42	+300%	+$455	﹤0.01%	3168
2024 Q1	$158	Buy	+14	New	+$181	﹤0.01%	3255

Other funds holding OLMA

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's OLMA Position: Q3 2026 in Review

GAMMA Investing reduced its Olema Pharmaceuticals (OLMA) stake by 6.9% in Q3 2026, selling an estimated $447 and leaving 555 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #3666.

GAMMA Investing first reported a position in OLMA in Q1 2024 and has held it in 9 quarters since. The position peaked at $18.1K in Q4 2025. 3 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

GAMMA Investing held 555 shares of Olema Pharmaceuticals worth $4.79K as of Q3 2026.
GAMMA Investing sold 41 Olema Pharmaceuticals shares in Q3 2026, an estimated $447.
Olema Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3666 holding.
GAMMA Investing first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
GAMMA Investing's Olema Pharmaceuticals position peaked at $18.1K in Q4 2025.
3 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.